# Diuretics and Volume Overload in Early CKD

> **NCT05171686** · PHASE4 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 49 (actual)

## Conditions studied

- Chronic Kidney Disease
- Hypertension

## Interventions

- **DRUG:** Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, or bumetanide)

## Key facts

- **NCT ID:** NCT05171686
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-01
- **Primary completion:** 2025-10-02
- **Final completion:** 2025-10-02
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05171686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05171686, "Diuretics and Volume Overload in Early CKD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05171686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*